Lilly Just Placed Million Bet on Injectables Boom
Lilly is backing Absci with a $40 million investment as Absci advances ABS-201, a next-gen injectable targeting hair ...
Why stock indices matter: they summarize market health and guide investment choices. This short intro highlights their practical value for you.
23,477 articlesLilly is backing Absci with a $40 million investment as Absci advances ABS-201, a next-gen injectable targeting hair ...
The S&P 500 trades at 22x forward earnings, but a deeper look at cash flow reveals a 32x multiple, driven by AI-relat...
Jim Cramer has spotlighted a widening valuation gap between NVIDIA and SanDisk, calling it the 'most insulting trade'...
A televised flare-up between two high-profile personalities reveals more than drama—it exposes how fame, endorsements...
Kick off your week with a focused investing routine. This article shares 10 Tuesday AM Reads you can digest in 15 min...
OpenAI investor Vinod Khosla signals alignment with Trump on AI policy as U.S.-China tech tensions surge. The stance ...
In a volatile market, three names stand out for reliable income: Realty Income, EPR Properties, and Verizon. Each del...
Looking for a higher yield consistent dividend or steady dividend growth? This in-depth guide compares VIG and FDVV, ...
A $3 million retirement nest egg offers substantial income options, but taxes, Medicare costs, and withdrawal strateg...
A newly launched dividend strategy ETF seeks to offer both a solid income stream and rising dividends, challenging th...
Ford surprised markets with an upward revision to its 2026 guidance after a solid first quarter. This article breaks ...
Toyo’s Q1 2026 earnings kick off a pivotal year for the company. This article breaks down the numbers, the commentary...